4 Other than being on GLP-1s, higher risk patients include: those in the dose-escalation phase and those with upper GI symptoms (eg, nausea, vomiting, dyspepsia, abdominal distension, and abdominal discomfort/pain). 4 And obviously, other high-risk group includes patients with comorbidities associated with delayed gastric emptying (eg, poorly controlled diabetes, Parkinsons disease, bowel dysmotility) as well as those on other drugs that slow gastric emptying (eg, opioids, tricyclic antidepressants, marijuana, alcohol)
Also, for speeding up the metabolic process, try splitting the dose if you have a slow metabolism
Biophysics 671, 203209
Each vial contains 70 mg total powder at 99.9% stated purity, combining BPC-157 (10 mg), TB-500 (10 mg
They also observed the reduced MG and oxidative stress under short term heat stress (42 C, 24 and 48 h)
I really appreciate this very technical brand, but I recognize that it can be quite intimidating at first glance